MAPT and Alzheimer disease: Subsequently, the dementia syndrome is removed from the 2016 IWG‐AA and the 2018 NIA‐AA criteria, which only require abnormal biomarkers for Aβ and tau for an AD diagnosis (Table 1, Figure 2).27, 29